• CARB-X has given Prompt Diagnostics LLC a $1 million grant to create a portable, quick diagnostic test for antibiotic-resistant gonorrhea.

• The company will use the grant to develop its cartridge-based polymerase chain reaction (PCR) platform further, which is portable and capable of detecting multiple targets of pathogenic bacteria and identifying mutations that confer antibiotic resistance.

• In low- and middle-income nations, where access to secondary healthcare facilities is restricted, and gonorrhea and the burden of resistance are more prevalent, the inexpensive test may be very helpful.

• The urgency of combating drug-resistant bacterial infections worldwide cannot be overstated. 

• Fast, high-tech diagnostics are a crucial tool in this battle, as they can identify infections at the earliest stage and guide medical professionals toward the most effective treatment.

Click here to read more.